Core77

Designers at the Institute of Design offer solutions in the face of a direct-to-consumer advertising ban, by Brianna Sylver. Here's a taste:

Congressional FDA hearings conducted in the latter part of 2005 have the pharmaceutical industry on edge, anticipating how the advertising regulations regarding the use of branded communications will change over the next two years. Wanting to stay ahead of change and to demonstrate how applying a bit of creative thinking to a sticky situation can result in innovative solutions, the following question was posed to the class: "If pharmaceutical companies can no longer present branded promotions through traditional DTC advertising channels, how else might they continue to reach healthcare consumers?"...

[Read full article here.]

Tweet

More: Featured Items • Comments (0)